APO Research
Talk to an analyst

APO RESEARCH · REPORT

Galectin 3

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Galectin 3 Industry Growth and Trends Forecast to 2032

22 December 202598 pages

Choose your research edition.

Industry ResearchGalectin 3 Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Galectin 3 Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Galectin 3 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Galectin 3 Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Galectin 3 Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Galectin 3 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Galectin 3 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Galectin 3 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Galectin 3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Galectin 3 include MandalMed Inc, iTeos Therapeutics SA, GlycoMimetics Inc, Galectin Therapeutics Inc, Bristol-Myers Squibb Company and Angion Biomedica Corp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Galectin 3 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Galectin 3 market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Galectin 3 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Galectin 3.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Galectin 3 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Galectin 3 Market by Company

MandalMed Inc

iTeos Therapeutics SA

GlycoMimetics Inc

Galectin Therapeutics Inc

Bristol-Myers Squibb Company

Angion Biomedica Corp

Galectin 3 Segment by Type

KTI

GRMD-03

GAL-300

ANG-4021

Others

Galectin 3 Segment by Application

Metastatic Melanoma

Portal Hypertension

Liver Cirrhosis

Others

Galectin 3 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Galectin 3 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Galectin 3 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Galectin 3.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Galectin 3 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Galectin 3 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of KTI Table 2. Major Company of GRMD-03 Table 3. Major Company of GAL-300 Table 4. Major Company of ANG-4021 Table 5. Major Company of Others Table 6. Global Galectin 3 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Galectin 3 Sales by Type (2021-2026) & (k units) Table 8. Global Galectin 3 Sales Market Share in Volume by Type (2021-2026) Table 9. Global Galectin 3 Sales by Type (2021-2026) & (US$ Million) Table 10. Global Galectin 3 Sales Market Share in Value by Type (2021-2026) Table 11. Global Galectin 3 Price by Type (2021-2026) & (US$/unit) Table 12. Global Galectin 3 Sales by Type (2027-2032) & (k units) Table 13. Global Galectin 3 Sales Market Share in Volume by Type (2027-2032) Table 14. Global Galectin 3 Sales by Type (2027-2032) & (US$ Million) Table 15. Global Galectin 3 Sales Market Share in Value by Type (2027-2032) Table 16. Global Galectin 3 Price by Type (2027-2032) & (US$/unit) Table 17. North America Galectin 3 Sales by Type (2021-2026) & (k units) Table 18. North America Galectin 3 Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Galectin 3 Sales by Type (2021-2026) & (k units) Table 20. Europe Galectin 3 Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Galectin 3 Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Galectin 3 Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Galectin 3 Sales by Type (2021-2026) & (k units) Table 24. Latin America Galectin 3 Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Galectin 3 Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Galectin 3 Sales by Type (2021-2026) & (US$ Million) Table 27. Galectin 3 Industry Trends Table 28. Galectin 3 Industry Drivers Table 29. Galectin 3 Industry Opportunities and Challenges Table 30. Galectin 3 Industry Restraints Table 31. Global Galectin 3 Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Galectin 3 Revenue Market Share by Company (2021-2026) Table 33. Global Galectin 3 Sales by Company (2021-2026) & (k units) Table 34. Global Galectin 3 Sales Share by Company (2021-2026) Table 35. Global Galectin 3 Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Galectin 3 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Galectin 3 Major Company Production Sites and Headquarters Table 38. Global Galectin 3 Company, Product Type & Application Table 39. Global Galectin 3 Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Galectin 3 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Galectin 3 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Galectin 3 Sales by Region (2021-2026) & (k units) Table 44. Global Galectin 3 Sales Market Share in Volume by Region (2021-2026) Table 45. Global Galectin 3 Sales by Region (2021-2026) & (US$ Million) Table 46. Global Galectin 3 Sales Market Share in Value by Region (2021-2026) Table 47. Global Galectin 3 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Galectin 3 Sales by Region (2027-2032) & (k units) Table 49. Global Galectin 3 Sales Market Share in Volume by Region (2027-2032) Table 50. Global Galectin 3 Sales by Region (2027-2032) & (US$ Million) Table 51. Global Galectin 3 Sales Market Share in Value by Region (2027-2032) Table 52. Global Galectin 3 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Galectin 3 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Galectin 3 Sales by Application (2021-2026) & (k units) Table 55. Global Galectin 3 Sales Market Share in Volume by Application (2021-2026) Table 56. Global Galectin 3 Sales by Application (2021-2026) & (US$ Million) Table 57. Global Galectin 3 Sales Market Share in Value by Application (2021-2026) Table 58. Global Galectin 3 Price by Application (2021-2026) & (US$/unit) Table 59. Global Galectin 3 Sales by Application (2027-2032) & (k units) Table 60. Global Galectin 3 Sales Market Share in Volume by Application (2027-2032) Table 61. Global Galectin 3 Sales by Application (2027-2032) & (US$ Million) Table 62. Global Galectin 3 Sales Market Share in Value by Application (2027-2032) Table 63. Global Galectin 3 Price by Application (2027-2032) & (US$/unit) Table 64. North America Galectin 3 Sales by Application (2021-2026) & (k units) Table 65. North America Galectin 3 Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Galectin 3 Sales by Application (2021-2026) & (k units) Table 67. Europe Galectin 3 Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Galectin 3 Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Galectin 3 Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Galectin 3 Sales by Application (2021-2026) & (k units) Table 71. Latin America Galectin 3 Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Galectin 3 Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Galectin 3 Sales by Application (2021-2026) & (US$ Million) Table 74. MandalMed Inc Company Information Table 75. MandalMed Inc Business Overview Table 76. MandalMed Inc Galectin 3 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. MandalMed Inc Galectin 3 Product Portfolio Table 78. MandalMed Inc Recent Development Table 79. iTeos Therapeutics SA Company Information Table 80. iTeos Therapeutics SA Business Overview Table 81. iTeos Therapeutics SA Galectin 3 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. iTeos Therapeutics SA Galectin 3 Product Portfolio Table 83. iTeos Therapeutics SA Recent Development Table 84. GlycoMimetics Inc Company Information Table 85. GlycoMimetics Inc Business Overview Table 86. GlycoMimetics Inc Galectin 3 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. GlycoMimetics Inc Galectin 3 Product Portfolio Table 88. GlycoMimetics Inc Recent Development Table 89. Galectin Therapeutics Inc Company Information Table 90. Galectin Therapeutics Inc Business Overview Table 91. Galectin Therapeutics Inc Galectin 3 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Galectin Therapeutics Inc Galectin 3 Product Portfolio Table 93. Galectin Therapeutics Inc Recent Development Table 94. Bristol-Myers Squibb Company Company Information Table 95. Bristol-Myers Squibb Company Business Overview Table 96. Bristol-Myers Squibb Company Galectin 3 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Bristol-Myers Squibb Company Galectin 3 Product Portfolio Table 98. Bristol-Myers Squibb Company Recent Development Table 99. Angion Biomedica Corp Company Information Table 100. Angion Biomedica Corp Business Overview Table 101. Angion Biomedica Corp Galectin 3 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Angion Biomedica Corp Galectin 3 Product Portfolio Table 103. Angion Biomedica Corp Recent Development Table 104. North America Galectin 3 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 105. North America Galectin 3 Sales by Country (2021-2026) & (k units) Table 106. North America Galectin 3 Sales Market Share by Country (2021-2026) Table 107. North America Galectin 3 Sales Forecast by Country (2027-2032) & (k units) Table 108. North America Galectin 3 Sales Market Share Forecast by Country (2027-2032) Table 109. North America Galectin 3 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 110. North America Galectin 3 Market Size by Country (2021-2026) & (US$ Million) Table 111. North America Galectin 3 Market Share by Country (2021-2026) Table 112. North America Galectin 3 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 113. North America Galectin 3 Market Share Forecast by Country (2027-2032) Table 114. Europe Galectin 3 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 115. Europe Galectin 3 Sales by Country (2021-2026) & (k units) Table 116. Europe Galectin 3 Sales Market Share by Country (2021-2026) Table 117. Europe Galectin 3 Sales Forecast by Country (2027-2032) & (k units) Table 118. Europe Galectin 3 Sales Market Share Forecast by Country (2027-2032) Table 119. Europe Galectin 3 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. Europe Galectin 3 Market Size by Country (2021-2026) & (US$ Million) Table 121. Europe Galectin 3 Market Share by Country (2021-2026) Table 122. Europe Galectin 3 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. Europe Galectin 3 Market Share Forecast by Country (2027-2032) Table 124. Asia-Pacific Galectin 3 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 125. Asia-Pacific Galectin 3 Sales by Country (2021-2026) & (k units) Table 126. Asia-Pacific Galectin 3 Sales Market Share by Country (2021-2026) Table 127. Asia-Pacific Galectin 3 Sales Forecast by Country (2027-2032) & (k units) Table 128. Asia-Pacific Galectin 3 Sales Market Share Forecast by Country (2027-2032) Table 129. Asia-Pacific Galectin 3 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Asia-Pacific Galectin 3 Market Size by Country (2021-2026) & (US$ Million) Table 131. Asia-Pacific Galectin 3 Market Share by Country (2021-2026) Table 132. Asia-Pacific Galectin 3 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Asia-Pacific Galectin 3 Market Share Forecast by Country (2027-2032) Table 134. Latin America Galectin 3 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 135. Latin America Galectin 3 Sales by Country (2021-2026) & (k units) Table 136. Latin America Galectin 3 Sales Market Share by Country (2021-2026) Table 137. Latin America Galectin 3 Sales Forecast by Country (2027-2032) & (k units) Table 138. Latin America Galectin 3 Sales Market Share Forecast by Country (2027-2032) Table 139. Latin America Galectin 3 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Latin America Galectin 3 Market Size by Country (2021-2026) & (US$ Million) Table 141. Latin America Galectin 3 Market Share by Country (2021-2026) Table 142. Latin America Galectin 3 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Latin America Galectin 3 Market Share Forecast by Country (2027-2032) Table 144. Middle East and Africa Galectin 3 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 145. Middle East and Africa Galectin 3 Sales by Country (2021-2026) & (k units) Table 146. Middle East and Africa Galectin 3 Sales Market Share by Country (2021-2026) Table 147. Middle East and Africa Galectin 3 Sales Forecast by Country (2027-2032) & (k units) Table 148. Middle East and Africa Galectin 3 Sales Market Share Forecast by Country (2027-2032) Table 149. Middle East and Africa Galectin 3 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Middle East and Africa Galectin 3 Market Size by Country (2021-2026) & (US$ Million) Table 151. Middle East and Africa Galectin 3 Market Share by Country (2021-2026) Table 152. Middle East and Africa Galectin 3 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Middle East and Africa Galectin 3 Market Share Forecast by Country (2027-2032) Table 154. Key Raw Materials Table 155. Raw Materials Key Suppliers Table 156. Galectin 3 Distributors List Table 157. Galectin 3 Customers List Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. Galectin 3 Image Figure 2. Global Galectin 3 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Galectin 3 Market Size (2021-2032) & (US$ Million) Figure 4. Global Galectin 3 Sales (2021-2032) & (k units) Figure 5. KTI Image Figure 6. Global KTI Sales YoY Growth (2021-2032) & (k units) Figure 7. GRMD-03 Image Figure 8. Global GRMD-03 Sales YoY Growth (2021-2032) & (k units) Figure 9. GAL-300 Image Figure 10. Global GAL-300 Sales YoY Growth (2021-2032) & (k units) Figure 11. ANG-4021 Image Figure 12. Global ANG-4021 Sales YoY Growth (2021-2032) & (k units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Galectin 3 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Galectin 3 Market Share by Type 2025 VS 2032 Figure 17. North America Galectin 3 Sales Market Share in Volume by Type in 2025 Figure 18. North America Galectin 3 Sales Market Share in Value by Type in 2025 Figure 19. Europe Galectin 3 Sales Market Share in Volume by Type in 2025 Figure 20. Europe Galectin 3 Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Galectin 3 Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Galectin 3 Sales Market Share in Value by Type in 2025 Figure 23. Latin America Galectin 3 Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Galectin 3 Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Galectin 3 Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Galectin 3 Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Galectin 3 Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Metastatic Melanoma Image Figure 30. Global Metastatic Melanoma Sales YoY Growth (2021-2032) & (k units) Figure 31. Portal Hypertension Image Figure 32. Global Portal Hypertension Sales YoY Growth (2021-2032) & (k units) Figure 33. Liver Cirrhosis Image Figure 34. Global Liver Cirrhosis Sales YoY Growth (2021-2032) & (k units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 37. Global Galectin 3 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Galectin 3 Market Share by Application 2025 VS 2032 Figure 39. North America Galectin 3 Sales Market Share in Volume by Application in 2025 Figure 40. North America Galectin 3 Sales Market Share in Value by Application in 2025 Figure 41. Europe Galectin 3 Sales Market Share in Volume by Application in 2025 Figure 42. Europe Galectin 3 Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Galectin 3 Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Galectin 3 Sales Market Share in Value by Application in 2025 Figure 45. Latin America Galectin 3 Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Galectin 3 Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Galectin 3 Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Galectin 3 Sales Market Share in Value by Application in 2025 Figure 49. North America Galectin 3 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. North America Galectin 3 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Galectin 3 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Galectin 3 Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Galectin 3 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Europe Galectin 3 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Galectin 3 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Galectin 3 Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Galectin 3 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Asia-Pacific Galectin 3 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Galectin 3 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Galectin 3 Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Galectin 3 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Latin America Galectin 3 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Galectin 3 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Galectin 3 Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Galectin 3 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 66. Middle East and Africa Galectin 3 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Galectin 3 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Galectin 3 Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Galectin 3 Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Galectin 3 Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • KTI
  • GRMD-03
  • GAL-300
  • ANG-4021
  • Others
Applications
  • Metastatic Melanoma
  • Portal Hypertension
  • Liver Cirrhosis
  • Others
Companies covered
  • MandalMed Inc
  • iTeos Therapeutics SA
  • GlycoMimetics Inc
  • Galectin Therapeutics Inc
  • Bristol-Myers Squibb Company
  • Angion Biomedica Corp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Galectin 3 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Galectin 3 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Galectin 3 Market by Type
  6. 1.3.1 KTI
  7. 1.3.2 GRMD-03
  8. 1.3.3 GAL-300
  9. 1.3.4 ANG-4021
  10. 1.3.5 Others
  11. 1.4 Global Galectin 3 Market Size by Type
  12. 1.4.1 Global Galectin 3 Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Galectin 3 Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Galectin 3 Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Galectin 3 Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Galectin 3 Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Galectin 3 Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Galectin 3 Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Galectin 3 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Galectin 3 Industry Trends
  2. 2.2 Galectin 3 Industry Drivers
  3. 2.3 Galectin 3 Industry Opportunities and Challenges
  4. 2.4 Galectin 3 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Galectin 3 Revenue (2021-2026)
  2. 3.2 Global Top Players by Galectin 3 Sales (2021-2026)
  3. 3.3 Global Top Players by Galectin 3 Price (2021-2026)
  4. 3.4 Global Galectin 3 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Galectin 3 Major Company Production Sites & Headquarters
  6. 3.6 Global Galectin 3 Company, Product Type & Application
  7. 3.7 Global Galectin 3 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Galectin 3 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Galectin 3 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Galectin 3 Tier 1, Tier 2, and Tier 3
4 Galectin 3 Regional Status and Outlook
  1. 4.1 Global Galectin 3 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Galectin 3 Historic Market Size by Region
  3. 4.2.1 Global Galectin 3 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Galectin 3 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Galectin 3 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Galectin 3 Forecasted Market Size by Region
  7. 4.3.1 Global Galectin 3 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Galectin 3 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Galectin 3 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Galectin 3 by Application
  1. 5.1 Galectin 3 Market by Application
  2. 5.1.1 Metastatic Melanoma
  3. 5.1.2 Portal Hypertension
  4. 5.1.3 Liver Cirrhosis
  5. 5.1.4 Others
  6. 5.2 Global Galectin 3 Market Size by Application
  7. 5.2.1 Global Galectin 3 Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Galectin 3 Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Galectin 3 Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Galectin 3 Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Galectin 3 Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Galectin 3 Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Galectin 3 Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Galectin 3 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 MandalMed Inc
  2. 6.1.1 MandalMed Inc Company Information
  3. 6.1.2 MandalMed Inc Business Overview
  4. 6.1.3 MandalMed Inc Galectin 3 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 MandalMed Inc Galectin 3 Product Portfolio
  6. 6.1.5 MandalMed Inc Recent Developments
  7. 6.2 iTeos Therapeutics SA
  8. 6.2.1 iTeos Therapeutics SA Company Information
  9. 6.2.2 iTeos Therapeutics SA Business Overview
  10. 6.2.3 iTeos Therapeutics SA Galectin 3 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 iTeos Therapeutics SA Galectin 3 Product Portfolio
  12. 6.2.5 iTeos Therapeutics SA Recent Developments
  13. 6.3 GlycoMimetics Inc
  14. 6.3.1 GlycoMimetics Inc Company Information
  15. 6.3.2 GlycoMimetics Inc Business Overview
  16. 6.3.3 GlycoMimetics Inc Galectin 3 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GlycoMimetics Inc Galectin 3 Product Portfolio
  18. 6.3.5 GlycoMimetics Inc Recent Developments
  19. 6.4 Galectin Therapeutics Inc
  20. 6.4.1 Galectin Therapeutics Inc Company Information
  21. 6.4.2 Galectin Therapeutics Inc Business Overview
  22. 6.4.3 Galectin Therapeutics Inc Galectin 3 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Galectin Therapeutics Inc Galectin 3 Product Portfolio
  24. 6.4.5 Galectin Therapeutics Inc Recent Developments
  25. 6.5 Bristol-Myers Squibb Company
  26. 6.5.1 Bristol-Myers Squibb Company Company Information
  27. 6.5.2 Bristol-Myers Squibb Company Business Overview
  28. 6.5.3 Bristol-Myers Squibb Company Galectin 3 Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bristol-Myers Squibb Company Galectin 3 Product Portfolio
  30. 6.5.5 Bristol-Myers Squibb Company Recent Developments
  31. 6.6 Angion Biomedica Corp
  32. 6.6.1 Angion Biomedica Corp Company Information
  33. 6.6.2 Angion Biomedica Corp Business Overview
  34. 6.6.3 Angion Biomedica Corp Galectin 3 Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Angion Biomedica Corp Galectin 3 Product Portfolio
  36. 6.6.5 Angion Biomedica Corp Recent Developments
7 North America by Country
  1. 7.1 North America Galectin 3 Sales by Country
  2. 7.1.1 North America Galectin 3 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Galectin 3 Sales by Country (2021-2026)
  4. 7.1.3 North America Galectin 3 Sales Forecast by Country (2027-2032)
  5. 7.2 North America Galectin 3 Market Size by Country
  6. 7.2.1 North America Galectin 3 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Galectin 3 Market Size by Country (2021-2026)
  8. 7.2.3 North America Galectin 3 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Galectin 3 Sales by Country
  2. 8.1.1 Europe Galectin 3 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Galectin 3 Sales by Country (2021-2026)
  4. 8.1.3 Europe Galectin 3 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Galectin 3 Market Size by Country
  6. 8.2.1 Europe Galectin 3 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Galectin 3 Market Size by Country (2021-2026)
  8. 8.2.3 Europe Galectin 3 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Galectin 3 Sales by Country
  2. 9.1.1 Asia-Pacific Galectin 3 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Galectin 3 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Galectin 3 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Galectin 3 Market Size by Country
  6. 9.2.1 Asia-Pacific Galectin 3 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Galectin 3 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Galectin 3 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Galectin 3 Sales by Country
  2. 10.1.1 South America Galectin 3 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Galectin 3 Sales by Country (2021-2026)
  4. 10.1.3 South America Galectin 3 Sales Forecast by Country (2027-2032)
  5. 10.2 South America Galectin 3 Market Size by Country
  6. 10.2.1 South America Galectin 3 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Galectin 3 Market Size by Country (2021-2026)
  8. 10.2.3 South America Galectin 3 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Galectin 3 Sales by Country
  2. 11.1.1 Middle East and Africa Galectin 3 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Galectin 3 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Galectin 3 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Galectin 3 Market Size by Country
  6. 11.2.1 Middle East and Africa Galectin 3 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Galectin 3 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Galectin 3 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Galectin 3 Value Chain Analysis
  2. 12.1.1 Galectin 3 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Galectin 3 Production Mode & Process
  7. 12.2 Galectin 3 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Galectin 3 Distributors
  10. 12.2.3 Galectin 3 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst